[1] LI H, XIAO Z, QUARLES LD, et al. Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development. Curr Med Chem. 2021;28(8):1489-1507.
[2] EL HAGE C, HALLIT S, AKEL M, et al. Osteoporosis awareness and health beliefs among Lebanese women aged 40 years and above. Osteoporos Int. 2019;30(4):771-786.
[3] JIN F, LI J, ZHANG YB, et al. A functional motif of long noncoding RNA Nron against osteoporosis. Nat Commun. 2021;12(1):3319.
[4] CHARLES RICHARD JL, EICHHORN PJA. Platforms for Investigating LncRNA Functions. SLAS Technol. 2018;23(6):493-506.
[5] LI D, YANG C, YIN C, et al. LncRNA, Important Player in Bone Development and Disease. Endocr Metab Immune Disord Drug Targets. 2020;20(1):50-66.
[6] GUO Q, GUO Q, XIAO Y, et al. Regulation of bone marrow mesenchymal stem cell fate by long non-coding RNA. Bone. 2020;141:115617.
[7] LI WY, XIONG H. Study on MSCs homing and its research on osteodiseases. Zhongguo Gu Shang. 2020;33(7):689-692.
[8] BAKER N, BOYETTE LB, TUAN RS. Characterization of bone marrow-derived mesenchymal stem cells in aging. Bone. 2015;70:37-47.
[9] CHEN Q, SHOU P, ZHENG C, et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. 2016;23(7): 1128-1139.
[10] YI S, YU M, YANG S, et al. Tcf12, A Member of Basic Helix-Loop-Helix Transcription Factors, Mediates Bone Marrow Mesenchymal Stem Cell Osteogenic Differentiation In Vitro and In Vivo. Stem Cells. 2017; 35(2):386-397.
[11] ZHANG W, DONG R, DIAO S, et al. Differential long noncoding RNA/mRNA expression profiling and functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells. Stem Cell Res Ther. 2017;8(1):30.
[12] XIAOLING G, SHUAIBIN L, KAILU L. MicroRNA-19b-3p promotes cell proliferation and osteogenic differentiation of BMSCs by interacting with lncRNA H19. BMC Med Genet. 2020;21(1):11.
[13] LI CJ, XIAO Y, YANG M, et al. Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging. J Clin Invest. 2018; 128(12):5251-5266.
[14] GUO J, REN R, YAO X, et al. PKM2 suppresses osteogenesis and facilitates adipogenesis by regulating β-catenin signaling and mitochondrial fusion and fission. Aging (Albany NY). 2020;12(4):3976-3992.
[15] MOTA DE SÁ P, RICHARD AJ, Hang H, et al. Transcriptional Regulation of Adipogenesis. Compr Physiol. 2017;7(2):635-674.
[16] SHANG G, WANG Y, XU Y, et al. Long non-coding RNA TCONS_00041960 enhances osteogenesis and inhibits adipogenesis of rat bone marrow mesenchymal stem cell by targeting miR-204-5p and miR-125a-3p. J Cell Physiol. 2018;233(8):6041-6051.
[17] CHEN S, LI Y, ZHI S, et al. lncRNA Xist Regulates Osteoblast Differentiation by Sponging miR-19a-3p in Aging-induced Osteoporosis. Aging Dis. 2020;11(5):1058-1068.
[18] OUYANG Z, TAN T, ZHANG X, et al. LncRNA ENST00000563492 promoting the osteogenesis-angiogenesis coupling process in bone mesenchymal stem cells (BMSCs) by functions as a ceRNA for miR-205-5p. Cell Death Dis. 2020;11(6):486.
[19] LI Z, JIN C, CHEN S, et al. Long non-coding RNA MEG3 inhibits adipogenesis and promotes osteogenesis of human adipose-derived mesenchymal stem cells via miR-140-5p. Mol Cell Biochem. 2017; 433(1-2):51-60.
[20] WU R, RUAN J, SUN Y, et al. Long non-coding RNA HIF1A-AS2 facilitates adipose-derived stem cells (ASCs) osteogenic differentiation through miR-665/IL6 axis via PI3K/Akt signaling pathway. Stem Cell Res Ther. 2018;9(1):348.
[21] YU L, QU H, YU Y, et al. LncRNA-PCAT1 targeting miR-145-5p promotes TLR4-associated osteogenic differentiation of adipose-derived stem cells. J Cell Mol Med. 2018;22(12):6134-6147.
[22] JIN C, ZHENG Y, HUANG Y, et al. Long non-coding RNA MIAT knockdown promotes osteogenic differentiation of human adipose-derived stem cells. Cell Biol Int. 2017;41(1):33-41.
[23] KIM JM, LIN C, STAVRE Z, et al. Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells. 2020;9(9):2073.
[24] SUN Y, CAI M, ZHONG J, et al. The long noncoding RNA lnc-ob1 facilitates bone formation by upregulating Osterix in osteoblasts. Nat Metab. 2019;1(4):485-496.
[25] YANG X, YANG J, LEI P, et al. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging (Albany NY). 2019;11(20):8777-8791.
[26] WANG X, HE J, WANG H, et al. Fluid shear stress regulates osteoblast proliferation and apoptosis via the lncRNA TUG1/miR-34a/FGFR1 axis. J Cell Mol Med. 2021;25(18):8734-8747.
[27] YIN C, TIAN Y, YU Y, et al. A novel long noncoding RNA AK016739 inhibits osteoblast differentiation and bone formation. J Cell Physiol. 2019;234(7):11524-11536.
[28] WANG C, XIE Q, SUN W, et al. lncRNA WT1-AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53. Exp Ther Med. 2021;22(1):734.
[29] CAI N, LI C, WANG F. Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2. Yonsei Med J. 2019;60(8):751-759.
[30] QIAN G, YU Y, DONG Y, et al. LncRNA AWPPH is downregulated in osteoporosis and regulates type I collagen α1 and α2 ratio. Arch Physiol Biochem. 2020:1-5. doi: 10.1080/13813455.2020.1767150. Online ahead of print.
[31] CHEN RS, ZHANG XB, ZHU XT, et al. LncRNA Bmncr alleviates the progression of osteoporosis by inhibiting RANML-induced osteoclast differentiation. Eur Rev Med Pharmacol Sci. 2019;23(21):9199-9206.
[32] UDAGAWA N, KOIDE M, NAKAMURA M, et al. Osteoclast differentiation by RANKL and OPG signaling pathways. J Bone Miner Metab. 2021; 39(1):19-26.
[33] HE Y, CHEN Y. The potential role of lncRNAs in osteoporosis. J Bone Miner Metab. 2021;39(3):341-352.
[34] LING L, HU HL, LIU KY, et al. Long noncoding RNA MIRG induces osteoclastogenesis and bone resorption in osteoporosis through negative regulation of miR-1897. Eur Rev Med Pharmacol Sci. 2019; 23(23):10195-10203.
[35] BOYCE BF, XIU Y, LI J, et al. NF-kappaB-Mediated Regulation of Osteoclastogenesis. Endocrinol Metab (Seoul). 2015;30(1):35-44.
[36] REN Y, ZHANG K, WANG J, et al. HOTAIRM1 promotes osteogenic differentiation and alleviates osteoclast differentiation by inactivating the NF-κB pathway. Acta Biochim Biophys Sin (Shanghai). 2021;53(2): 201-211.
[37] YASUDA H. Discovery of the RANKL/RANK/OPG system. J Bone Miner Metab. 2021;39(1):2-11.
[38] CHE W, DONG Y, QUAN HB. RANKL inhibits cell proliferation by regulating MALAT1 expression in a human osteoblastic cell line hFOB 1.19. Cell Mol Biol (Noisy-le-grand). 2015;61(1):7-14.
[39] CHANG Y, YU D, CHU W, et al. LncRNA expression profiles and the negative regulation of lncRNA-NOMMUT037835.2 in osteoclastogenesis. Bone. 2020;130:115072.
[40] LI VS, NG SS, BOERSEMA PJ, et al. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell. 2012;149(6): 1245-1256.
[41] CAI WL, ZENG W, LIU HH, et al. LncRNA LINC00707 promotes osteogenic differentiation of hBMSCs through the Wnt/β-catenin pathway activated by LINC00707/miR-145/LRP5 axis. Eur Rev Med Pharmacol Sci. 2020;24(1):18-28.
[42] LIU J, WU M, FENG G, et al. Downregulation of LINC00707 promotes osteogenic differentiation of human bone marrow‑derived mesenchymal stem cells by regulating DKK1 via targeting miR‑103a‑3p. Int J Mol Med. 2020;46(3):1029-1038.
[43] WANG CG, HU YH, SU SL, et al. LncRNA DANCR and miR-320a suppressed osteogenic differentiation in osteoporosis by directly inhibiting the Wnt/β-catenin signaling pathway. Exp Mol Med. 2020; 52(8):1310-1325.
[44] LIU ZH, QI DD, LI X, et al. LncRNA SNHG14 promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells via regulating miR-185-5p/WISP2 axis. J Biol Regul Homeost Agents. 2021;35(2):605-615.
[45] LOWERY JW, ROSEN V. The BMP Pathway and Its Inhibitors in the Skeleton. Physiol Rev. 2018;98(4):2431-2452.
[46] ZHAO Y, CHEN Y, HU X, et al. lncRNA LINC01535 upregulates BMP2 expression levels to promote osteogenic differentiation via sponging miR‑3619‑5p. Mol Med Rep. 2020;22(6):5428-5435.
[47] ZHANG RF, LIU JW, YU SP, et al. LncRNA UCA1 affects osteoblast proliferation and differentiation by regulating BMP-2 expression. Eur Rev Med Pharmacol Sci. 2019;23(16):6774-6782.
[48] ZHANG Y, CHEN B, LI D, et al. LncRNA NEAT1/miR-29b-3p/BMP1 axis promotes osteogenic differentiation in human bone marrow-derived mesenchymal stem cells. Pathol Res Pract. 2019;215(3):525-531.
[49] KOPAN R, ILAGAN MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216-233.
[50] ZANOTTI S, CANALIS E. Notch and the skeleton. Mol Cell Biol. 2010; 30(4):886-896.
[51] ZHANG Z, LIU J, ZENG Z, et al. lncRNA Rmst acts as an important mediator of BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) by antagonizing Notch-targeting microRNAs. Aging (Albany NY). 2019;11(24):12476-12496.
[52] CHE M, GONG W, ZHAO Y, et al. Long noncoding RNA HCG18 inhibits the differentiation of human bone marrow-derived mesenchymal stem cells in osteoporosis by targeting miR-30a-5p/NOTCH1 axis. Mol Med. 2020;26(1):106.
[53] YU Y, YAO P, WANG Z, et al. Down-regulation of FTX promotes the differentiation of osteoclasts in osteoporosis through the Notch1 signaling pathway by targeting miR-137. BMC Musculoskelet Disord. 2020;21(1):456.
[54] WANG H, ZHAO W, TIAN QJ, et al. Effect of lncRNA AK023948 on rats with postmenopausal osteoporosis via PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(5):2181-2188.
[55] WANG H, LI YK, CUI M, et al. Effect of lncRNA AK125437 on postmenopausal osteoporosis rats via MAPK pathway. Eur Rev Med Pharmacol Sci. 2020;24(5):2173-2180.
[56] WU Y, JIANG Y, LIU Q, et al. lncRNA H19 promotes matrix mineralization through up-regulating IGF1 by sponging miR-185-5p in osteoblasts. BMC Mol Cell Biol. 2019;20(1):48.
[57] MURACA M, CAPPARIELLO A. The Role of Extracellular Vesicles (EVs) in the Epigenetic Regulation of Bone Metabolism and Osteoporosis. Int J Mol Sci. 2020;21(22):8682.
[58] YANG Y, YUJIAO W, FANG W, et al. The roles of miRNA, lncRNA and circRNA in the development of osteoporosis. Biol Res. 2020;53(1):40.
[59] YU L, LIU Y. circRNA_0016624 could sponge miR-98 to regulate BMP2 expression in postmenopausal osteoporosis. Biochem Biophys Res Commun. 2019;516(2):546-550.
|